Español
India
Italiano
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
RAYZEBIO INC COM
RYZB
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
15 minutes delayed
Get Report
Watch
RAYZEBIO INC COM (RYZB) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for RAYZEBIO INC COM (NASDAQ:RYZB) Stock
RAYZEBIO INC COM Stock (NASDAQ: RYZB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, March 19, 2024
AstraZeneca's $2.4B Fusion Pharmaceuticals' Acquisition Signals Shift In Efforts From Traditional Regimens For More Targeted Cancer Treatments
Vandana Singh
Monday, February 12, 2024
Bristol Myers Squibb And Rayzebio Announced E...
Benzinga Newsdesk
Friday, January 05, 2024
Cramer Says This 'Inexpensive' Stock Is 'Doing Some Great Things With Aerospace'
Avi Kapoor
Friday, December 29, 2023
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
Vandana Singh
Wednesday, December 27, 2023
Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned
Vandana Singh
Investor Sentiment Improves; Dow Jumps Over 150 Points
Avi Kapoor
Tuesday, December 26, 2023
Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
Avi Kapoor
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
William Blair Downgrades RayzeBio to Market P...
Benzinga Newsdesk
Health Care Company Bristol-Myers Squibb Announces Merger With RayzeBio
Benzinga Insights
Bristol Myers Squibb Takes On Novartis, Eli Lilly With RayzeBio $4B Deal In Radiopharmaceuticals
Vandana Singh
RayzeBio shares are trading higher after the ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Bristol Myers Squibb Adds Premier Radiopharma...
Benzinga Newsdesk
Monday, November 13, 2023
RayzeBio Q3 EPS $(1.26) Up From $(6.55) YoY
Benzinga Newsdesk
Tuesday, October 24, 2023
FDA Selects RayzeBio To Participate In Inaugu...
Benzinga Newsdesk
Wednesday, October 11, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023
Benzinga Insights
Evercore ISI Group Initiates Coverage On Rayz...
Benzinga Newsdesk
Tuesday, October 10, 2023
RayzeBio Is A New Contender in Radiopharmaceutical Arena, Will Attract Prominent Entities: JP Morgan
Vandana Singh
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
Benzinga Insights
Truist Securities Initiates Coverage On Rayze...
Benzinga Newsdesk
JP Morgan Initiates Coverage On RayzeBio with...
Benzinga Newsdesk
Jefferies Initiates Coverage On RayzeBio with...
Benzinga Newsdesk
Friday, October 06, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
Benzinga Insights
William Blair Initiates Coverage On RayzeBio ...
Benzinga Newsdesk
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, September 15, 2023
RayzeBio Indicating $23.40 On 262K Shares
Benzinga Newsdesk
RayzeBio Prices Upsized $311M Initial Public ...
Benzinga Newsdesk
Thursday, September 14, 2023
Rayzebio, Inc IPOs Tomorrow, Here's What You Need To Know
Benzinga Insights